Rady Johnson
Rady Johnson is Executive Vice President and Pfizer’s Chief Compliance, Quality and Risk Officer. Rady was Chair of the IFPMA Ethics & Business Integrity Committee and Chief Ethics & Compliance Officers Roundtable from 2020-2022. At Pfizer, he has overall responsibility for the company's global compliance program, Regulatory Quality Assurance organization, global security program, and Office of the Ombudsman. Since joining Pfizer in 1994, Rady has led the Regulatory Law practice group as well as the Corporate Regulatory and Healthcare Law Audit functions, established the Legal Division’s Global Products Counsel practice group, and served as Senior Vice President and Associate General …
Rady Johnson is Executive Vice President and Pfizer’s Chief Compliance, Quality and Risk Officer. Rady was Chair of the IFPMA Ethics & Business Integrity Committee and Chief Ethics & Compliance Officers Roundtable from 2020-2022. At Pfizer, he has overall responsibility for the company's global compliance program, Regulatory Quality Assurance organization, global security program, and Office of the Ombudsman. Since joining Pfizer in 1994, Rady has led the Regulatory Law practice group as well as the Corporate Regulatory and Healthcare Law Audit functions, established the Legal Division’s Global Products Counsel practice group, and served as Senior Vice President and Associate General Counsel for the innovative segments of Pfizer’s Worldwide Biopharmaceuticals Business.
See more
Articles: Rady Johnson
Ethoscope: Biopharma Industry Unveils Novel Platform to Promote Ethics & Business Integrity
Global / Takeda’s Mwana Lugogo and Pfizer’s Rady Johnson, the current and former chairs of the IFPMA Ethics & Business Integrity Committee and Chief Ethics & Compliance Officers Roundtable respectively, highlight the IFPMA’s new ‘Ethoscope’ initiative, which aims to promote ethics and business integrity throughout the industry to sustain and develop trust. As an industry dedicated…
Latest Report
